In particular, in vitro studies with T cells isolated from jejunal mucosa or peripheral blood of CeD patients demonstrated that following deamidation by tissue transglutaminase (tTG), glutamine and proline enriched GIPs enhance their capability to stimulate adaptive immune response in CeD patients (5–9). Here, TGM2 is linked to cranioectodermal dysplasia.